B |
2020-11-10 10:18:57.0 |
StepStone Group Inc |
STEP |
WELLINGTON MANAGEMENT GROUP LLP |
10.04% |
view |
B |
2020-03-19 16:42:32.0 |
Strongbridge Biopharma plc |
SBBP |
Ikarian Capital |
6.0% |
view |
S |
2020-02-14 11:00:37.0 |
Strongbridge Biopharma plc |
SBBP |
Broadfin Capital |
1.09% |
view |
S |
2020-02-06 16:16:14.0 |
Strongbridge Biopharma plc |
SBBP |
Vivo Capital VIII |
1.9% |
view |
S |
2019-02-14 14:21:15.0 |
Strongbridge Biopharma plc |
SBBP |
Broadfin Capital |
5.38% |
view |
B |
2019-02-12 17:13:02.0 |
Strongbridge Biopharma plc |
SBBP |
HealthCap VI |
100.0% |
view |
B |
2018-12-28 16:42:34.0 |
Strongbridge Biopharma plc |
SBBP |
NOVO NORDISK A S |
10.0% |
view |
S |
2018-11-09 07:09:04.0 |
Strongbridge Biopharma plc |
SBBP |
CAXTON CORP |
17.4% |
view |
S |
2018-06-22 16:30:44.0 |
Strongbridge Biopharma plc |
n/a |
Opaleye Management Inc |
0.0% |
view |
S |
2018-02-14 10:58:04.0 |
Strongbridge Biopharma plc |
n/a |
ARMISTICE CAPITAL |
7.21% |
view |
B |
2018-02-12 16:35:39.0 |
Strongbridge Biopharma plc |
n/a |
Vivo Capital VIII |
9.3% |
view |
B |
2017-10-10 12:35:22.0 |
Strongbridge Biopharma plc |
n/a |
CAXTON CORP |
5.1% |
view |
B |
2017-02-14 19:14:41.0 |
Strongbridge Biopharma plc |
n/a |
RA Capital Healthcare Fund LP |
0.0% |
view |
S |
2017-02-10 15:38:41.0 |
Strongbridge Biopharma plc |
n/a |
Spetalen Eigil Stray |
3.25% |
view |
B |
2017-01-17 16:00:32.0 |
Strongbridge Biopharma plc |
n/a |
Vivo Capital VIII |
8.52% |
view |
B |
2017-01-06 15:31:08.0 |
Strongbridge Biopharma plc |
n/a |
CAXTON CORP |
15.3% |
view |
B |
2016-09-29 09:36:05.0 |
Strongbridge Biopharma plc |
n/a |
STOREBRAND ASSET MANAGEMENT AS |
10.1% |
view |
B |
2016-02-08 11:58:34.0 |
Strongbridge Biopharma plc |
n/a |
Spetalen Eigil Stray |
8.0% |
view |
B |
2016-01-13 12:16:58.0 |
Strongbridge Biopharma plc |
n/a |
Broadfin Capital |
10.1% |
view |